tiprankstipranks
Trending News
More News >
Zealand Pharma (ZLDPF)
OTHER OTC:ZLDPF
US Market
Advertisement

Zealand Pharma (ZLDPF) Ratios

Compare
150 Followers

Zealand Pharma Ratios

ZLDPF's free cash flow for Q1 2025 was kr0.95. For the 2025 fiscal year, ZLDPF's free cash flow was decreased by kr and operating cash flow was kr-40.67. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
25.10 6.25 6.73 5.15 2.16
Quick Ratio
25.07 6.23 6.73 4.80 2.08
Cash Ratio
2.18 1.58 5.47 3.38 1.49
Solvency Ratio
-1.43 -1.75 -1.29 -0.87 -1.08
Operating Cash Flow Ratio
-3.38 -1.50 -4.82 -3.63 -1.19
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 8.14Bkr 1.39Bkr 592.46Mkr 581.77Mkr 497.51M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.06 0.29 0.38 0.06
Debt-to-Equity Ratio
0.05 0.07 0.54 0.85 0.10
Debt-to-Capital Ratio
0.05 0.07 0.35 0.46 0.09
Long-Term Debt-to-Capital Ratio
0.03 0.00 0.28 0.41 0.00
Financial Leverage Ratio
1.10 1.24 1.89 2.23 1.64
Debt Service Coverage Ratio
-12.99 -22.31 -15.56 -176.21 -204.01
Interest Coverage Ratio
-16.71 -19.75 -14.46 -256.71 -286.27
Debt to Market Cap
0.01 0.00 0.03 0.10 0.00
Interest Debt Per Share
6.80 2.62 10.82 18.46 3.20
Net Debt to EBITDA
0.34 0.51 0.71 0.47 1.27
Profitability Margins
Gross Profit Margin
93.39%94.41%70.47%59.39%74.37%
EBIT Margin
-2045.23%-198.34%-880.49%-257.99%-189.81%
EBITDA Margin
-1994.72%-190.08%-850.96%-249.41%-165.16%
Operating Profit Margin
-2555.76%-166.94%-785.30%-358.96%-234.57%
Pretax Profit Margin
-2136.97%-206.79%-934.78%-351.01%-237.65%
Net Profit Margin
-2128.64%-205.30%-928.60%-348.01%-239.65%
Continuous Operations Profit Margin
-2128.64%-205.30%-928.60%-258.04%-189.27%
Net Income Per EBT
99.61%99.28%99.34%99.14%100.84%
EBT Per EBIT
83.61%123.88%119.04%97.79%101.31%
Return on Assets (ROA)
-13.00%-35.54%-62.71%-49.24%-43.99%
Return on Equity (ROE)
-13.47%-44.18%-118.35%-109.74%-71.93%
Return on Capital Employed (ROCE)
-16.24%-33.75%-60.74%-60.59%-61.53%
Return on Invested Capital (ROIC)
-16.15%-33.18%-59.69%-59.56%-61.41%
Return on Tangible Assets
-13.02%-35.76%-62.71%-50.56%-44.83%
Earnings Yield
-4.56%-3.33%-10.38%-16.37%-10.00%
Efficiency Ratios
Receivables Turnover
0.37 2.80 0.90 1.91 7.60
Payables Turnover
0.02 0.21 0.17 0.45 1.29
Inventory Turnover
0.34 2.42 23.88 1.00 1.98
Fixed Asset Turnover
0.43 2.29 0.63 1.32 1.76
Asset Turnover
<0.01 0.17 0.07 0.14 0.18
Working Capital Turnover Ratio
<0.01 0.26 0.08 0.28 0.37
Cash Conversion Cycle
-22.18K -1.46K -1.73K -263.07 -51.46
Days of Sales Outstanding
982.26 130.29 405.84 191.44 48.02
Days of Inventory Outstanding
1.06K 151.05 15.28 363.84 184.18
Days of Payables Outstanding
24.22K 1.74K 2.15K 818.35 283.67
Operating Cycle
2.04K 281.34 421.13 555.28 232.20
Cash Flow Ratios
Operating Cash Flow Per Share
-17.11 -7.52 -20.39 -28.27 -17.95
Free Cash Flow Per Share
-17.37 -7.94 -20.65 -28.79 -18.60
CapEx Per Share
0.26 0.42 0.25 0.52 0.65
Free Cash Flow to Operating Cash Flow
1.02 1.06 1.01 1.02 1.04
Dividend Paid and CapEx Coverage Ratio
-65.74 -17.92 -80.46 -54.76 -27.50
Capital Expenditure Coverage Ratio
-65.74 -17.92 -80.46 -54.76 -27.50
Operating Cash Flow Coverage Ratio
-3.06 -3.57 -2.12 -1.54 -5.75
Operating Cash Flow to Sales Ratio
-21.69 -1.24 -9.06 -4.14 -1.95
Free Cash Flow Yield
-4.69%-2.13%-10.25%-19.84%-8.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-21.91 -30.01 -9.64 -6.11 -10.00
Price-to-Sales (P/S) Ratio
469.04 61.61 89.48 21.26 23.96
Price-to-Book (P/B) Ratio
3.13 13.26 11.40 6.70 7.19
Price-to-Free Cash Flow (P/FCF) Ratio
-21.30 -46.99 -9.75 -5.04 -11.86
Price-to-Operating Cash Flow Ratio
-21.51 -49.61 -9.88 -5.13 -12.29
Price-to-Earnings Growth (PEG) Ratio
3.48 0.74 0.80 -0.80 -0.33
Price-to-Fair Value
3.13 13.26 11.40 6.70 7.19
Enterprise Value Multiple
-23.17 -31.91 -9.81 -8.06 -13.24
Enterprise Value
25.74B 20.79B 8.68B 5.88B 7.72B
EV to EBITDA
-23.17 -31.91 -9.81 -8.06 -13.24
EV to Sales
462.19 60.65 83.46 20.09 21.86
EV to Free Cash Flow
-20.99 -46.26 -9.10 -4.76 -10.82
EV to Operating Cash Flow
-21.31 -48.84 -9.21 -4.85 -11.21
Tangible Book Value Per Share
117.69 27.93 17.66 20.39 29.75
Shareholders’ Equity Per Share
117.69 28.15 17.66 21.64 30.68
Tax and Other Ratios
Effective Tax Rate
<0.01 <0.01 <0.01 <0.01 >-0.01
Revenue Per Share
0.79 6.06 2.25 6.82 9.21
Net Income Per Share
-16.79 -12.44 -20.90 -23.75 -22.07
Tax Burden
1.00 0.99 0.99 0.99 1.01
Interest Burden
1.04 1.04 1.06 1.36 1.25
Research & Development to Revenue
18.30 2.00 5.91 2.01 1.71
SG&A to Revenue
2.87 0.22 2.64 0.89 0.57
Stock-Based Compensation to Revenue
1.65 0.18 0.50 0.18 0.09
Income Quality
1.02 0.60 0.78 1.19 0.81
Currency in DKK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis